Subscribe To
IMGO / Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone
Content Topics
Imago
Biosciences
Bone
Marrow
Cancer
Researcher
Reaches
Biosciences
Milestone
Stock
IMGO
IMGO News
By Seeking Alpha
November 30, 2022
Imago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestone
Imago BioSciences becomes part of the Merck & Co., Inc. family for $1.35 billion. Imago BioSciences, Inc. will certainly strengthen Merck's position i more_horizontal
By Zacks Investment Research
November 22, 2022
Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck
Imago BioSciences (IMGO) to be acquired by pharma-giant Merck (MRK) for $1.35 billion. The transaction is likely to close by first-quarter 2023. more_horizontal
By Zacks Investment Research
February 28, 2022
Why Earnings Season Could Be Great for Imago BioSciences (IMGO)
Imago BioSciences (IMGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal
By Zacks Investment Research
February 28, 2022
Why Earnings Season Could Be Great for Imago BioSciences (IMGO)
Imago BioSciences (IMGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal
By Zacks Investment Research
February 28, 2022
Why Earnings Season Could Be Great for Imago BioSciences (IMGO)
Imago BioSciences (IMGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal